ECSP066672A - Métodos para tratar asma - Google Patents
Métodos para tratar asmaInfo
- Publication number
- ECSP066672A ECSP066672A EC2006006672A ECSP066672A ECSP066672A EC SP066672 A ECSP066672 A EC SP066672A EC 2006006672 A EC2006006672 A EC 2006006672A EC SP066672 A ECSP066672 A EC SP066672A EC SP066672 A ECSP066672 A EC SP066672A
- Authority
- EC
- Ecuador
- Prior art keywords
- pkc
- methods
- agents
- protein
- inhibit
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
- G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
Abstract
La presente invención se refiere a métodos para agentes útiles para tratar asma. Los métodos incluyen seleccionar agentes que inhiben la producción de una proteína PKC-?, así como también agentes que inhiben la actividad de cinasa de una proteína PKC-?, o un fragmento funcional de la misma, en donde tales agentes son útiles para tratar el asma. También se incluyen métodos para seleccionar agentes que inhiben la producción de un producto de gen reportero codificado por una secuencia de ácido nucleico operablemente ligada a un promotor de PKC-?. También se describen métodos para tratar asma que incluyen, administrar un agente que inhibe la producción de una proteína PKC-? funcional o la actividad de cinasa de una proteína PKC-? o un fragmento funcional de la misma. También se describe una célula mástil aislada que carece de la expresión de una PKC-? endógena.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53252503P | 2003-12-24 | 2003-12-24 | |
US58941504P | 2004-07-20 | 2004-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP066672A true ECSP066672A (es) | 2006-10-25 |
Family
ID=34743021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2006006672A ECSP066672A (es) | 2003-12-24 | 2006-06-23 | Métodos para tratar asma |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050164323A1 (es) |
EP (1) | EP1702214A4 (es) |
JP (1) | JP2007525210A (es) |
KR (1) | KR20060127415A (es) |
AU (1) | AU2004308441A1 (es) |
BR (1) | BRPI0417212A (es) |
CA (1) | CA2545722A1 (es) |
CR (1) | CR8398A (es) |
EC (1) | ECSP066672A (es) |
IL (1) | IL175351A0 (es) |
MX (1) | MXPA06007094A (es) |
NO (1) | NO20062496L (es) |
RU (1) | RU2006126704A (es) |
WO (1) | WO2005062918A2 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
JP4668902B2 (ja) | 2003-08-07 | 2011-04-13 | ヒーラー リミテッド | 創傷治癒を促進するための薬剤組成物及び方法 |
US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
AR049390A1 (es) * | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
US20090098142A1 (en) * | 2004-06-09 | 2009-04-16 | Kasaian Marion T | Methods and compositions for treating and monitoring treatment of IL-13-associated disorders |
DE102005020754B3 (de) * | 2005-05-02 | 2007-01-11 | Altana Pharma Ag | Zelluläres Assayverfahren zur Identifizierung von PKCtheta-Inhibitoren |
NZ566083A (en) * | 2005-08-29 | 2012-11-30 | Healor Ltd | Methods and compositions for prevention and treatment of diabetic and aged skin |
US7883855B2 (en) | 2006-07-21 | 2011-02-08 | Abbott Laboratories | Immunosuppressant drug extraction reagent for immunoassays |
GB0617222D0 (en) * | 2006-08-31 | 2006-10-11 | Vereniging Het Nl Kanker I | Antibiotics |
CA2673314C (en) | 2006-12-29 | 2014-03-11 | Abbott Laboratories | Non-denaturing lysis reagent for use with capture-in-solution immunoassay |
ES2393135T3 (es) | 2006-12-29 | 2012-12-18 | Abbott Laboratories | Ensayo mejorado para fármacos inmunosupresores |
JP5450092B2 (ja) * | 2006-12-29 | 2014-03-26 | アボット・ラボラトリーズ | 全血中の分子または薬物の検出のための診断検査 |
US7914999B2 (en) * | 2006-12-29 | 2011-03-29 | Abbott Laboratories | Non-denaturing lysis reagent |
US20090155784A1 (en) * | 2007-01-22 | 2009-06-18 | Wyeth | Assessment of asthma and allergen-dependent gene expression |
TW200848429A (en) * | 2007-04-23 | 2008-12-16 | Wyeth Corp | Methods and compositions for treating and monitoring treatment of IL-13-associated disorders |
US20100310542A1 (en) * | 2007-07-30 | 2010-12-09 | Healor Ltd. | Pharmaceutical Compositions for treating wouds and related methods |
WO2010017473A2 (en) * | 2008-08-07 | 2010-02-11 | The Salk Institute For Biological Studies | Method of identifying ikk2 activators or inhibitors |
EP2389373B1 (en) | 2009-01-21 | 2017-05-17 | Rigel Pharmaceuticals, Inc. | Derivatives of n2-(3-pyridyl or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases |
EP2507227B1 (en) | 2009-12-01 | 2014-10-08 | Rigel Pharmaceuticals, Inc. | Tetrazolones as protein kinase c inhibitors and uses thereof |
CA2801781C (en) | 2010-07-21 | 2018-02-27 | Rigel Pharmaceuticals, Inc. | Protein kinase c inhibitors and uses thereof |
RU2526146C2 (ru) * | 2012-09-27 | 2014-08-20 | Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) | Способ профилактики и лечения бронхиальной астмы, осложняющих ее респираторных вирусных инфекций и других воспалительных заболеваний дыхательных путей |
WO2014089112A1 (en) | 2012-12-04 | 2014-06-12 | Rigel Pharmaceuticals, Inc. | Protein kinase c inhibitors and uses thereof |
JP6421170B2 (ja) | 2013-03-14 | 2018-11-07 | ライジェル ファーマシューティカルズ, インコーポレイテッド | プロテインキナーゼc阻害剤およびその使用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012530A1 (en) * | 1992-11-30 | 1994-06-09 | Biosignal Kutató Fejlesztó Kft. | Polyunsaturated fatty acyl-peptide composition |
US5776716A (en) * | 1994-02-01 | 1998-07-07 | Terrapin Technologies, Inc. | Methods for identifying agents which block the interaction of fyn with PKC-theta, and uses thereof |
US5935803A (en) * | 1994-02-01 | 1999-08-10 | Terrapin Technologies, Inc. | Methods to identify immunomodulators using cognate interaction of PKC-theta |
US6054286A (en) * | 1996-06-18 | 2000-04-25 | Telik, Inc. | Methods to identify immunomodulators using cognate interaction of PKC-theta |
US6040152A (en) * | 1996-12-31 | 2000-03-21 | National Jewish Medical And Research Center | Method and assay for regulation of T cell proliferation |
US6103712A (en) * | 1998-03-05 | 2000-08-15 | Eli Lilly And Company | Therapeutic treatment for asthma |
CA2343934A1 (en) * | 1998-09-25 | 2000-04-06 | The Children's Medical Center Corporation | Short peptides which selectively modulate the activity of protein kinases |
AU2481800A (en) * | 1998-12-17 | 2000-07-03 | La Jolla Institute For Allergy And Immunology | Pkc-interacting cousin of trx (picot) polypeptides, polynucleotides, and methodsof making and using them |
SE9902387D0 (sv) * | 1999-06-22 | 1999-06-22 | Astra Ab | New pharmaceutically active compounds |
US6190869B1 (en) * | 1999-10-26 | 2001-02-20 | Isis Pharmaceuticals, Inc. | Antisense inhibition of protein kinase C-theta expression |
AU2460601A (en) * | 1999-12-27 | 2001-07-09 | La Jolla Institute For Allergy | Methods for identifying agents capable of modulating protein kinase c theta (pkctheta) activity |
-
2004
- 2004-12-22 KR KR1020067012717A patent/KR20060127415A/ko not_active Application Discontinuation
- 2004-12-22 BR BRPI0417212-4A patent/BRPI0417212A/pt not_active IP Right Cessation
- 2004-12-22 AU AU2004308441A patent/AU2004308441A1/en not_active Withdrawn
- 2004-12-22 CA CA002545722A patent/CA2545722A1/en not_active Abandoned
- 2004-12-22 JP JP2006547362A patent/JP2007525210A/ja not_active Withdrawn
- 2004-12-22 EP EP04815366A patent/EP1702214A4/en not_active Withdrawn
- 2004-12-22 US US11/022,327 patent/US20050164323A1/en not_active Abandoned
- 2004-12-22 WO PCT/US2004/043281 patent/WO2005062918A2/en active Application Filing
- 2004-12-22 RU RU2006126704/15A patent/RU2006126704A/ru unknown
- 2004-12-22 MX MXPA06007094A patent/MXPA06007094A/es unknown
-
2006
- 2006-05-01 IL IL175351A patent/IL175351A0/en unknown
- 2006-05-11 CR CR8398A patent/CR8398A/es not_active Application Discontinuation
- 2006-05-31 NO NO20062496A patent/NO20062496L/no not_active Application Discontinuation
- 2006-06-23 EC EC2006006672A patent/ECSP066672A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1702214A4 (en) | 2007-12-19 |
BRPI0417212A (pt) | 2007-02-06 |
WO2005062918A3 (en) | 2005-08-25 |
NO20062496L (no) | 2006-09-11 |
RU2006126704A (ru) | 2008-01-27 |
AU2004308441A1 (en) | 2005-07-14 |
WO2005062918A2 (en) | 2005-07-14 |
MXPA06007094A (es) | 2006-08-23 |
US20050164323A1 (en) | 2005-07-28 |
EP1702214A2 (en) | 2006-09-20 |
KR20060127415A (ko) | 2006-12-12 |
IL175351A0 (en) | 2006-09-05 |
CA2545722A1 (en) | 2005-07-14 |
JP2007525210A (ja) | 2007-09-06 |
CR8398A (es) | 2006-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066672A (es) | Métodos para tratar asma | |
AR047897A1 (es) | Composiciones y metodos que usan interferencia de arn para el control de nematodos | |
BR112018067442A2 (pt) | composto, composição farmacêutica, método de inibir a atividade da amina oxidase, método de tratar uma condição e uso de um composto | |
GT200200014A (es) | Inhibidores de piridina de metaloproteinasas de la matriz | |
WO2007065010A3 (en) | Anti-angiogenesis compounds | |
DE50311850D1 (de) | Konstrukte und verfahren zur regulation der genexpression | |
ECSP078060A (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
BRPI0507373A (pt) | compostos e método de uso | |
ATE408412T1 (de) | Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration | |
WO2010041913A3 (ko) | Grs 단백질 또는 이의 단편의 신규한 용도 | |
ECSP077299A (es) | Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos | |
AR036818A1 (es) | Composiciones y metodos para promover resistencia a nematodos en plantas | |
PA8608201A1 (es) | Compuestos de indazol 3,5-disustituidos, composiciones farmaceuticas y metodos para intervenir en o inhibir la proliferacion celular | |
GT200800265A (es) | Pirido (3,2-e)piracinas, su uso como inhibidores de fosfadiesterasa 10, y procesos para prepararlas. | |
PA8556201A1 (es) | Alquinos como inhibidores de metaloproteinasa de matriz | |
GT200400133AA (es) | Derivados de pirrolo[3,4-c] pirazol, activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden. (solicitud fraccionaria no. 1, derivada de la patente no. pi-2004-0133). | |
IN2012DN01345A (es) | ||
MX360085B (es) | Identificacion de mutaciones de channelopsin-2 (chop2) y los metodos de uso. | |
UY27924A1 (es) | Compuestos tipo diarilureas fluoradas | |
WO2005090572A3 (en) | Compositions and methods for treating pancreatic cancer | |
UY27232A1 (es) | Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos | |
MX2013010524A (es) | Combinacion de oligonucleotido anti-clusterina con inhibidor hsp90 para el tratamiento de cancer de prostata. | |
GT200300271A (es) | Derivados del acido isoftalico | |
CO2023011154A2 (es) | Composiciones y métodos para tratar angioedema hereditario | |
PA8642901A1 (es) | Amidas del acido 5 y 6-aminoalquil indol-2-carboxilico 3-sustituidas y analogos relacionados como inhibidores de la caseina cinasa i |